 |
EBMT To view Candidates |
  EBMT Special Sessions & Events |
Corporate Symposia at EBMT 2008 |
The EBMT 2008 meeting will open on Sunday 30th March with a full and exciting satellite symposia programme, carefully developed in collaboration with the scientific committee to complement the main scientific programme. Sixteen symposia are scheduled for Sunday and we strongly encourage delegates to arrive on Saturday in order to take full advantage of Corporate Sunday programme which commences at 9 a.m. A preview of each company's Symposia agenda can be seen by clicking here and then selecting the company whose agenda you wish to view.
9.00 – 10.30 |
MSD Evidence based medicing in treating fungal infections in BMT patients |
Novartis Oncology Targeted therapy in CML |
Gentium SpA Update of clinical studies in Hepatic Veno-Occlusiv disease following STC |
medac GmbH Conditioning Therapy |
11.00 – 13.00 |
Genzyme Novel therapeutic approaches in HSCT and haematalogic disorders |
Celgene Multiple Myeloma: in pursuit of optimal treatment |
Pfizer Early therapy of invasive aspergilosis |
Miltenyi Biotec Cellular Therapy: one step closer to clinical practice |
13.30 – 15.30 |
Pharmion Current controversies in transplant management for MM patients |
Therakos Advances in management of patients with chrnoic GvHD |
Schering Plough A new standard of care in anti-fungal therapy |
Pierre Fabre Changing patient outcome in HSCT: the impact of IV Busulfan-based regimens |
16.00 – 18.00 |
Bayer Schering Painting a brighter future: improving clinical outcomes in transplant patients with NHL and CLL |
Alexion PNH: BMT or complement inhibition? |
Gilead Science Invasive fungal infections – translating guidelines into daily practice |
Fresenius Expansion of alternative donor sources for SCT |
session